Non-functional bladder paraganglioma in a patient with complex hematological disorders: case report

Author:

Puia DragosORCID,Pricop Catalin

Abstract

Abstract Background Although bladder cancer is quite a common cancer, most common encounter being transitional cell carcinomas, paragangliomas with such localization, is a very rare histopathological finding. In addition, hematuria in a patient with a theoretically "hypercoagulable" condition is uncommon; in our case it was the single symptom. Case presentation We report the case of a 44-year-old female referred to our hospital for gross hematuria. The CT scan revealed an intraluminal enhancing bladder mass. Also, the XIII coagulation factor level was 36% and surprisingly genetic mutations suggesting inherited thrombophilia were found: MTHFR C677T negative, A1298C positive and PAI-1 gene polymorphism (675 4G/5G). The hematologist recommended folic acid 5 mgs daily. A TURBT was performed (macroscopically no residual tumor tissue). The immunohistochemical examination revealed tumor cells intensely positive to chromogranin and synaptophysin, negative for cytokeratin AE1/3, p63, 7, 20 or CDX2, and slight (less than 5%) positive for Ki-67. The combined examinations correspond to a bladder paraganglioma. Six months after surgery, the patient had no clinical symptoms and no relapse sonographically and cystoscopically. Conclusions Although a very rare entity, bladder paraganglioma should be suspected in patients with hematuria and unexplained hyperadrenalism symptoms such as hypertension, serious dizziness, headache or palpitation. The immunohistochemical examination is important not only for diagnosis but also for identifying the functionality of the tumors. In such cases the therapeutic management could be different as in transitional cell carcinomas.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Reference14 articles.

1. Ferlay J, Colombet M, Soerjomataram L et al. Global and Regional Estimates of the Incidence and Mortality for 38 Cancers: GLOBOCAN 2018. Lyon: International Agency for Research on Cancer/World Health Organization; 2018. http://gco.iarc.fr/

2. Zimmerman IJ, Biron RE, MacMahon HE (1953) Pheochromocytoma of the urinary bladder. N Engl J Med 249(1):25–26. https://doi.org/10.1056/NEJM195307022490106

3. Pastor-Guzmán JM, López-García S, Giménez-Bachs JM, Ruíz-Mondejar R et al (2004) Paraganglioma of the bladder: controversy regarding treatment. Urol Int 73(3):270–275. https://doi.org/10.1159/000080841

4. Chen J (2006) Clinicopathologic study of paraganglioma. Chin J Pathol 35(8):494–496 (PMID: 17069706)

5. Siatelis A, Konstantinidis C, Volanis D et al (2008) Pheochromocytoma of the urinary bladder: report of 2 cases and review of literature. Minerva Urol Nefrol 60(2):137–140 (PMID: 18500228)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3